AstraZeneca recently released positive results from its POTOMAC Phase III trial involving IMFINZI, reflecting significant advancements in treatment for high-risk non-muscle-invasive bladder cancer.

Astrazeneca could be opening a new facility in Rockville. California Gas Prices Could Skyrocket 75%, Newsom Is Warned Law and Order: SVU fans mourn loss of two main characters in surprise shakeup ...

AstraZeneca, as part of its ongoing $3.5 billion investment in American innovation, opened its first U.S.-operated cell therapy factory in Maryland to help treat cancer patients. The U.K-based ...

THIS LAB ISN’T OPEN OR OPERATIONAL YET, BUT ONCE IT IS, THE FOLKS AT ASTRAZENECA BELIEVE IT IS ... SIT DOWN UNTIL IT’S DINNER TIME. THIS BUILDING AND THESE LABS ARE SCHEDULED TO OPEN IN ...

AstraZeneca Q1 sales rose 7% YoY to $13.59 billion, missing estimates; Earnings per ADS beat at $1.25 vs. $1.11 consensus. Oncology revenue jumped 10% to $5.64 billion; Tagrisso, Imfinzi, and ...

Pascal Soriot, Chief Executive Officer, AstraZeneca, said: "Our strong growth momentum has continued into 2025 and we have now entered an unprecedented catalyst-rich period for our company.

CAMBRIDGE, Britain (AP) — CAMBRIDGE, Britain (AP) — Astrazeneca PLC (AZN) on Tuesday reported first-quarter profit of $2.92 billion. On a per-share basis, the Cambridge, Britain-based company ...

AstraZeneca (AZN) CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on pharmaceuticals and said a more favorable corporate tax credit could motivate ...

By Damien Cave and Muktita Suhartono Reporting from Bangkok Only one building in Bangkok fell during the earthquake on Friday that rocked Myanmar, hundreds of miles away. Recovery efforts continue ...

March 21 (UPI) --AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational pharmaceutical announced Friday. The investment will mark the ...

AstraZeneca to buy EsoBiotec for up to $1 billion Deal aims to enhance cancer cell therapy capabilities AstraZeneca secures global rights to Alteogen's ALT-B4 enzyme AstraZeneca shares up almost ...

British pharmaceutical giant AstraZeneca on Monday announced an agreement to buy Belgian cell therapy firm EsoBiotec for up to $1 billion, expanding its treatments for cancer. EsoBiotec's ...